November 8, 2019 / 6:08 AM / 12 days ago

BRIEF-Cassiopea Announces FDA Acceptance Of Its New Drug Application For Clascoterone Cream 1%

Nov 8 (Reuters) - Cassiopea SpA:

* CASSIOPEA ANNOUNCES FDA ACCEPTANCE OF ITS NEW DRUG APPLICATION FOR CLASCOTERONE CREAM 1%, FIRST NEW MECHANISM OF ACTION FOR ACNE IN NEARLY 40 YEARS

* FDA HAS SET AUGUST 27, 2020 AS PRESCRIPTION DRUG USER FEE ACT (PDUFA) ACTION DATE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below